MediWiSe is a medtech knowledge-driven company that empowers individuals to take control of their health. Founded by a team of entrepreneurial individuals in London in 2010, MediWiSe is developing breakthrough solutions targeted at the big three: diabetes, cardiovascular disease and cancer. The team includes award winning scientists with proven track record in wireless devices, implantable and wearable sensors, physics, nanotechnology, imaging and intelligent algorithms. It also includes award-wining entrepreneurs and experienced executives specializing in medical devices commercialization, business and product development, as well as corporate and startup governance. MediWiSe has established strategic partnerships with medical institutions and received interest from industry leaders and it is the owner of three patents in the medical diagnostics field.
MediWiSe's core technology is metamaterials, i.e. manmade nanocomposite materials that enable non-invasive precision diagnostics. This technology has allowed MediWiSe to develop three wireless products for the medical diagnostics market: the first accurate, non-invasive on-ear glucose sensor and mobile platform for continuous diabetes management; the first radio-wave imaging scanner for early stage screening of breast cancer aimed at younger women; and the first real-time wearable radiation sensor for cancer patients undergoing radiotherapy treatments.
Medical wireless sensing is a rapidly developing scientific field which has the potential to revolutionise the medical diagnostics and monitoring devices markets. MediWise's mission is to lead this revolution, through the development of innovative technologies and solutions for industry and the wider research community.